Andrew Cheng

Andrew Cheng is currently Chairman, President & Chief Executive Officer at Avere Therapeutics, Inc. Dr. Cheng serves as Independent Director at Vera Therapeutics, Inc. since 2017.
Dr. Cheng is Director at Boys & Girls Clubs of Metro Los Angeles.
Dr. Cheng is Independent Director at TCGX Acquisition Corp.
starting in 2026.
Formerly, Dr. Cheng was President, Chief Executive Officer & Director at Akero Therapeutics, Inc. from 2018 to 2025.
Dr. Cheng was Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022.
Dr. Cheng was Director at Syntimmune, Inc. Dr. Cheng was Director at Global Virus Network.
Dr. Cheng was Non-Executive Director at MorphoSys AG from 2022 to 2024.
Dr. Cheng was Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. in 2018.
Dr. Cheng completed undergraduate studies at The Johns Hopkins University in 1988.
Dr. Cheng earned a doctorate from Columbia University College of Physicians & Surgeons in 1996.